SCWorx Announces Compliance with Nasdaq’s Periodic Reporting Listing Standard
SCWorx Corp. (Nasdaq: WORX) has successfully regained compliance with Nasdaq's continued listing requirements for periodic reporting. The company, which provides data management services to healthcare providers, had previously received non-compliance notifications from Nasdaq on April 17, May 17, and August 19, 2024, under Listing Rule 5250(c)(1).
Following the filing of their Form 10-K for 2023 and Forms 10-Q for Q1 and Q2 2024 on September 24, October 10, and October 11 respectively, Nasdaq confirmed compliance in a letter dated October 14, 2024. All previous deficiencies have been resolved, and SCWorx's common stock continues to trade on Nasdaq under the symbol WORX.
SCWorx Corp. (Nasdaq: WORX) ha riacquistato con successo la conformità ai requisiti di continua quotazione di Nasdaq per la segnalazione periodica. L'azienda, che fornisce servizi di gestione dei dati ai fornitori di assistenza sanitaria, aveva precedentemente ricevuto notifiche di non conformità da Nasdaq il 17 aprile, 17 maggio e 19 agosto 2024, secondo la Regola di Quotazione 5250(c)(1).
Dopo la presentazione del loro Modulo 10-K per il 2023 e dei Moduli 10-Q per il primo e il secondo trimestre del 2024, rispettivamente il 24 settembre, 10 ottobre e 11 ottobre, Nasdaq ha confermato la conformità in una lettera datata 14 ottobre 2024. Tutte le carenze precedenti sono state risolte e le azioni ordinarie di SCWorx continuano a essere scambiate su Nasdaq con il simbolo WORX.
SCWorx Corp. (Nasdaq: WORX) ha recuperado con éxito el cumplimiento de los requisitos de cotización continua de Nasdaq para informes periódicos. La empresa, que proporciona servicios de gestión de datos a proveedores de atención médica, había recibido anteriormente notificaciones de incumplimiento de Nasdaq el 17 de abril, 17 de mayo y 19 de agosto de 2024, bajo la Regla de Cotización 5250(c)(1).
Tras la presentación de su Formulario 10-K para 2023 y los Formularios 10-Q para el primer y segundo trimestre de 2024 el 24 de septiembre, 10 de octubre y 11 de octubre, respectivamente, Nasdaq confirmó el cumplimiento en una carta fechada el 14 de octubre de 2024. Todas las deficiencias anteriores han sido resueltas y las acciones comunes de SCWorx continúan negociándose en Nasdaq bajo el símbolo WORX.
SCWorx Corp. (Nasdaq: WORX)는 정기 보고를 위한 Nasdaq의 지속적인 상장 요건을 성공적으로 회복했습니다. 의료 제공자에게 데이터 관리 서비스를 제공하는 이 회사는 2024년 4월 17일, 5월 17일, 8월 19일에 Nasdaq로부터 비준수 통지를 받았습니다. 이는 상장 규칙 5250(c)(1)에 따른 것입니다.
2023년 10-K 양식과 2024년 1분기 및 2분기 용 10-Q 양식을 각각 9월 24일, 10월 10일 및 10월 11일에 제출한 후, Nasdaq은 2024년 10월 14일자 편지에서 준수를 확인했습니다. 모든 이전 결함이 해결되었으며, SCWorx의 보통주는 여전히 Nasdaq에서 WORX라는 기호로 거래되고 있습니다.
SCWorx Corp. (Nasdaq: WORX) a réussi à retrouver sa conformité avec les exigences de cotation continue de Nasdaq pour les rapports périodiques. L'entreprise, qui fournit des services de gestion des données aux prestataires de soins de santé, avait auparavant reçu des notifications de non-conformité de la part de Nasdaq les 17 avril, 17 mai et 19 août 2024, en vertu de la règle de cotation 5250(c)(1).
Après le dépôt de leur formulaire 10-K pour 2023 et des formulaires 10-Q pour le premier et le deuxième trimestre 2024 le 24 septembre, 10 octobre et 11 octobre respectivement, Nasdaq a confirmé la conformité dans une lettre datée du 14 octobre 2024. Tous les défauts précédents ont été résolus et les actions ordinaires de SCWorx continuent d'être négociées sur Nasdaq sous le symbole WORX.
SCWorx Corp. (Nasdaq: WORX) hat erfolgreich die Konformität mit den fortlaufenden Börsennotierungsanforderungen von Nasdaq für die regelmäßige Berichterstattung wiederhergestellt. Das Unternehmen, das Datenmanagementdienste für Gesundheitsdienstleister anbietet, hatte zuvor am 17. April, 17. Mai und 19. August 2024 von Nasdaq Benachrichtigungen über die Nichteinhaltung gemäß der Listing-Regel 5250(c)(1) erhalten.
Nach der Einreichung ihres Formulars 10-K für 2023 und der Formulare 10-Q für Q1 und Q2 2024 am 24. September, 10. Oktober und 11. Oktober, hat Nasdaq in einem Schreiben vom 14. Oktober 2024 die Konformität bestätigt. Alle vorherigen Mängel wurden behoben, und die Stammaktien von SCWorx werden weiterhin an der Nasdaq unter dem Symbol WORX gehandelt.
- None.
- None.
NEW YORK, N.Y., Nov. 20, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) (the “Company”), a provider of data management services to healthcare providers, announced today that it has regained compliance with The Nasdaq Stock Market’s (“Nasdaq”) continued listing requirements regarding periodic reporting.
On April 17, May 17, and August 19, 2024, Nasdaq notified the Company that it no longer met the Nasdaq’s periodic filing requirement under Listing Rule 5250(c)(1) (the “Rule”).
In a letter dated October 14, 2024, Nasdaq indicated that based on the September 24, October 10, and October 11, 2024, filing of the Company’s Form 10-K for the year ended December 31, 2023, and Forms 10-Q for the periods ended March 31, and June 30, 2024, respectively, Staff had determined that the Company complies with the Rule and that the matter was now closed.
At this time, all deficiencies of which the Company has been notified have been rectified, and Nasdaq considers these matters closed. As such, the Company’s common stock continues to be listed and trading on Nasdaq under the symbol “WORX”.
About SCWorx
SCWorx has created an advanced attributed virtualized item data warehouse utilizing machine learning and artificial intelligence to offer a suite of software-as-a-service-based solutions for healthcare providers. The value proposition for customers revolves around the full integration of all solution modules with the company’s data platform for cost savings, operational efficiency and accurate benchmarking and reporting. The solution modules include Virtual Item Master, data cleanse and normalization, contract management and request for pricing (RFP) module, automated rebate management module, data interoperability (EMR, MMIS, finance) module, Automated Item Add Portal, Virtual General Ledger, and the data analytics module. SCWorx creates a single source for information for the healthcare provider’s data governance and analytics requirements.
Forward-Looking Statements
This press release contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations, future contract renewals and terminations, future financial position, prospects, plans and objectives of management are forward-looking statements. You can identify many (but not all) such forward-looking statements by looking for words such as “assumes,” “approximates,” “believes,” “expects,” “anticipates,” “estimates,” “projects,” “seeks,” “intends,” “plans,” “could,” “would,” “may” or other similar expressions. You should not place undue reliance on these forward-looking statements. Such statements are based on management’s current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors, including, without limitation, economic disruptions affecting our customers, unexpected contract terminations, securing future contracts and orders, future product sourcing, supply disruptions, containing costs, the ability to project future cash utilization and reserves needed for contingent future liabilities and business operations, the availability of sufficient resources of the company to meet its business objectives and operational requirements and other important factors that are detailed in filings with the Securities and Exchange Commission made from time to time by SCWorx, including its Annual Report on Form 10-K for the year ended December 31, 2023, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Matters described in forward-looking statements may also be affected by other known and unknown risks, trends, uncertainties and factors, many of which are beyond the company’s ability to control or predict. SCWorx undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Contacts:
ir@scworx.com ###
Source: SCWorx Corp.
FAQ
When did SCWorx (WORX) regain Nasdaq compliance in 2024?
What Nasdaq rule did SCWorx (WORX) violate in 2024?
What financial reports did SCWorx (WORX) need to file to regain compliance?